Immunopathogenesis of hepatitis C virus in the immunosuppressed host

@article{Einav2002ImmunopathogenesisOH,
  title={Immunopathogenesis of hepatitis C virus in the immunosuppressed host},
  author={Shirit Einav and Margaret James Koziel and S., M.J. Einav Koziel},
  journal={Transplant Infectious Disease},
  year={2002},
  volume={4}
}
The prevalence of chronic hepatitis C virus (HCV) infection among various groups of immunosuppressed patients is high. These groups include patients co‐infected with human immunodeficiency virus (HIV), recipients of organ transplants, and those with hypogammaglobulinemia. The liver disease in the immunosuppressed host is typically severe with an unusually rapid progression to cirrhosis. This is somewhat paradoxical, as the classical model for HCV‐induced liver disease assumes that cell‐mediated… Expand
Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact
TLDR
This review will briefly outline the current knowledge about the pathogenesis of both hepatic and extrahepatic HCV-related disorders and the principal available data concerning HCV infection in a condition of impairment of the immune system. Expand
Hepatitis C virus and the immune system: a concise review
TLDR
The immune system partially controls the viral infection but due to a long‐lasting inflammatory milieu, hepatic damage occurs and HCV does not seem to be cytopathic during the chronic phase of the infection. Expand
Managing symptomatic drug-induced liver injury in HIV-hepatitis C virus-coinfected patients: a role for interferon.
  • B. McGovern, C. Birch, +8 authors R. Gandhi
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2007
TLDR
A novel mechanism for DILI is proposed, whereby HCV- and HIV-associated inflammatory mediators induce liver injury synergistically and the beneficial effects of IFN-based therapy may be modulated through the suppression of proinflammatory cytokines, even in virologic nonresponders. Expand
Management of Chronic Hepatitis C Virus Infection: Current Perspectives
TLDR
H hepatitis C virus infection leads to hepatic inflammation, steatosis, cirrhosis, and greater risk of hepatocellular carcinoma, and clinical manifestations include acute infection, chronic infection, non-hepatic complications, and occult infection. Expand
HIV and hepatitis C virus coinfection update
TLDR
Future studies will focus on understanding the pathogenesis of accelerated liver fibrosis in HIV-infected individuals, the natural history of HCV in the era of antiretroviral therapy, and the principles of managing these two infections within the same individual. Expand
Pathogenesis of Hepatitis C - HCV Consensus 2007
TLDR
Various studies have associated the progression of fibrosis in hepatitis C with diverse factors such as: the kinetics andpathogenicity of HCV; host-HCV interaction; intrinsic hostfactors such as demographic profile, body mass index and diabetes mellitus; host exposure to external factors; and the form ofHCV acquisition. Expand
Treatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug Therapy
TLDR
The results demonstrate that antiviral therapy can be safe and effective, and preliminary data reveal that these regimens may confer such benefits in immunosuppressed individuals as well. Expand
64 – Alcohol and Hepatitis Virus Interactions in Liver Pathology
TLDR
Hepatitis virus infection-caused liver injury in patients drinking alcohol cannot efficiently regenerate and repair, which may contribute to the collaborative effect of alcohol drinking and hepatitis virus on liver injury. Expand
HCV-Core Over-expressed Specifically in Liver Cells
TLDR
Although the DNA injection needs to be optimized, the results indicate that liver-specific expression may provide a new way to elucidate the pathogenesis of HCV infections. Expand
Hepatitis C virus dynamics and pathology: the role of CTL and antibody responses.
  • D. Wodarz
  • Biology, Medicine
  • The Journal of general virology
  • 2003
TLDR
The role of CTL and antibody responses in hepatitis C virus (HCV) dynamics and pathology is investigated and the relative balance of the immune response can be a decisive factor that determines whether patients are asymptomatic or whether pathology is observed. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 66 REFERENCES
Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence
TLDR
The dominant cause of viral persistence during HCV infection may be the development of a weak antiviral immune response to the viral antigens, with corresponding inability to eradicate infected cells. Expand
Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis.
TLDR
HIV-related immunodeficiency may be a determinant of higher hepatitis C viremia levels and more severe liver damage and mean interval from estimated time of HCV infection to cirrhosis was significantly longer in HIV-negative than HIV-positive patients. Expand
Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation.
TLDR
The inability to generate virus-specific T-cell responses plays a contributory role in the pathogenesis of HCV-related graft injury after liver transplantation and is suggested to provide the rationale for novel therapeutic strategies and diminish the incidence of inevitable graft loss. Expand
Immunohistochemical evidence of immunopathogenetic mechanisms in chronic hepatitis C recurrence after liver transplantation
TLDR
The level of viremia did not correlate with the degree of liver damage, and the severe forms of post‐transplant HCV infection recurrence are associated with a marked and aberrant intrahepatic expression of molecules involved in antigen recognition, and intercellular and vascular adhesion, decisive in regulating the recruitment and activation of cytotoxic T lymphocytes. Expand
A longitudinal analysis of hepatitis C virus replication following liver transplantation.
BACKGROUND & AIMS The pathogenesis of graft injury in liver transplant recipients with recurrent hepatitis C virus (HCV) infection remains poorly understood. In this study, the relationship betweenExpand
Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis.
TLDR
The presence of HCV-specific CTL at the site of tissue damage in persons with chronic HCV hepatitis is demonstrated and provided a means to evaluate the possible pathogenic role of these cells in HCV infection. Expand
Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.
TLDR
The data show that the number of IFN-gamma-producing HCV-specific CD8+ T cells during the first 6 months after onset of disease is associated with eradication of the HCV infection. Expand
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
TLDR
In coinfected patients, a low CD4 count, alcohol consumption rate, and age at HCV infection are associated with a higher liver fibrosis progression rate, while HIV seropositivity accelerates HCV‐related liver Fibrosis progression. Expand
Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus.
TLDR
It is suggested that HIV infection-induced CD4 depletion is independently associated with the severity of liver fibrosis in chronic HCV infection. Expand
Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia.
TLDR
The clinical course of HCV infection in patients with primary hypogammaglobulinaemia appears to be more severe than in immunocompetent patients, and patients with common variable immunodeficiency appear to have the poorest prognosis. Expand
...
1
2
3
4
5
...